MDPI and ACS Style
Rapoport, B.L.; Nayler, S.; Mlecnik, B.; Smit, T.; Heyman, L.; Bouquet, I.; Martel, M.; Galon, J.; Benn, C.-A.; Anderson, R.
Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response. Cancers 2022, 14, 2525.
https://doi.org/10.3390/cancers14102525
AMA Style
Rapoport BL, Nayler S, Mlecnik B, Smit T, Heyman L, Bouquet I, Martel M, Galon J, Benn C-A, Anderson R.
Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response. Cancers. 2022; 14(10):2525.
https://doi.org/10.3390/cancers14102525
Chicago/Turabian Style
Rapoport, Bernardo Leon, Simon Nayler, Bernhard Mlecnik, Teresa Smit, Liezl Heyman, Isabelle Bouquet, Marine Martel, Jérôme Galon, Carol-Ann Benn, and Ronald Anderson.
2022. "Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response" Cancers 14, no. 10: 2525.
https://doi.org/10.3390/cancers14102525